This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovations of Andreas Flörsheimer
Introduction
Andreas Flörsheimer is a notable inventor based in Möhlin, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tumor agents. His work has the potential to impact cancer treatment positively.
Latest Patents
Flörsheimer holds a patent for "Epothilone derivatives and their use as antitumor agents." This invention relates to anti-tumor-effective compounds of a specific formula, wherein the radicals have defined meanings as described in the patent documentation. His innovative approach to cancer treatment showcases his commitment to advancing medical science.
Career Highlights
Flörsheimer is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to collaborate with other experts in the field, enhancing the development of new therapeutic agents. His career reflects a dedication to research and innovation in pharmaceuticals.
Collaborations
Throughout his career, Flörsheimer has worked alongside notable colleagues such as Karl-Heinz Altmann and Guido Bold. These collaborations have contributed to the success of his research and the advancement of new medical treatments.
Conclusion
Andreas Flörsheimer's contributions to the field of pharmaceuticals, particularly through his patent on anti-tumor agents, highlight his role as an influential inventor. His work continues to inspire advancements in cancer treatment and showcases the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile